Biosimilar Insights
-
BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty
2/26/2025
On this episode of the Business of Biotech, recorded on-site at the 2025 JP Morgan Healthcare Conference, we explore a new approach to biotech financing with XOMA Royalty's Owen Hughes and Brad Sitko. The CEO and CIO, respectively, share an innovative royalty aggregation model that mitigates risk while enabling immediate capital access to biotech firms.
-
Biologics Technology Transfer Guidebook
2/26/2025
Explore why technology transfer is a critical component in mammalian biologic drug development and manufacturing with the essential guide to biologics tech transfer that covers key strategies, best practices, and critical considerations.
-
Multi-Attribute Method Analysis In Biopharmaceutical Development
2/26/2025
Analytics is a crucial element in biopharmaceutical development and manufacturing. Discover how Multi-Attribute Method (MAM) revolutionizes analytics to enhance quality control and regulatory compliance.
-
mRNA Vaccines And Therapeutics: Current Trends And Perspectives
2/25/2025
Delve into the advancements and transformative impact of mRNA vaccine technology on modern medicine and explore how this technology is revolutionizing healthcare for the future and beyond.
-
Gain Speed To GMP Filling
2/24/2025
Discover the advantages of a filling technology that provides faster readiness to good manufacturing practices (GMP) filling compared with traditional options.
-
Key Regulatory Considerations For The Next Wave Of Gene Therapies
2/21/2025
The evolving field of viral vector production, driven by advances in gene and cell therapies, is facing increasing regulatory scrutiny and analytical demands.
-
Tackling Encapsidated Host Cell DNA To Improve Quality
2/19/2025
Discover a cell line that enhances rAAV production by reducing host cell DNA encapsidation, improving safety and efficiency through genetic modifications that inhibit apoptotic DNA fragmentation.
-
Introduction To Tangential Flow Filtration
2/5/2025
Learn about tangential flow filtration (TFF), typical TFF system configurations, ultrafiltration fundamentals, applications, system selection considerations, and more.
-
Primer Support 5G For Oligonucleotide Synthesis Product Demo
2/3/2025
Primer Support™ 5G solid support is the fifth-generation solid support for oligonucleotide synthesis from Cytiva. By using Cytiva consumables, you can better leverage the whole family knowledge and expertise to efficiently optimize your molecule’s development.
-
ÄKTA Oligosynt™ Synthesizer: With A Little Help From Its Friends
2/3/2025
Cytiva is just about that initial oligo synthesis right? Wrong! Find out all about the synthesis systems friends and family across the full oligo workflow.